IOL Chemicals shareholders approve FY26 financials, reappoint director
- Shareholders approved adoption of FY26 standalone and consolidated audited financial statements
- Kushal Kumar Rana was reappointed as director after retiring by rotation
- Cost auditor remuneration for FY27 was ratified by shareholders
- 92 shareholders attended the virtual AGM, including five promoters and 87 public investors
*this image is generated using AI for illustrative purposes only.
IOL Chemicals and Pharmaceuticals held its 39th Annual General Meeting on September 2, 2026. Shareholders approved the adoption of standalone and consolidated audited financial statements for FY26, alongside other key governance resolutions.
The company conducted the proceedings via Video Conferencing and Other Audio Visual Means in compliance with SEBI regulations and the Companies Act, 2013. Mr. Rajender Mohan Malla, Chairman of the Board, presided over the meeting after confirming the requisite quorum was present. Mr. Abhay Raj Singh, Senior Vice President and Company Secretary, welcomed participants including members, directors, statutory auditors, and the scrutinizer.
Resolutions Passed
Shareholders approved three ordinary resolutions during the meeting. The key decisions included:
| Resolution | Type | Status |
|---|---|---|
| Adoption of Standalone and Consolidated Audited Financial Statements for FY26 | Ordinary | Passed |
| Re-appointment of Mr. Kushal Kumar Rana as Director | Ordinary | Passed |
| Ratification of Cost Auditor Remuneration for FY27 | Ordinary | Passed |
The members received, considered, and adopted the standalone and consolidated audited financial statements for the financial year ended March 31, 2026. This included the reports of the Board of Directors and the auditors.
Governance and Audit Details
Mr. Kushal Kumar Rana retired by rotation and offered himself for re-appointment as a director. The shareholders approved his re-appointment. The company also ratified the remuneration of the Cost Auditor for the financial year ending March 31, 2027.
M/s. Ashwani & Associates served as Statutory Auditors, while M/s. B.K. Gupta & Associates acted as Secretarial Auditors. Both audit reports were free of qualifications, observations, or comments that could adversely affect the company’s functioning.
Voting Participation
Mr. Vinay Kohli, Partner at M/s. K.K. Kapoor & Associates, was appointed as the Scrutinizer to oversee the e-voting process. Remote e-voting was available from August 30, 2026, to September 1, 2026. Members who did not vote remotely could cast their votes electronically during the AGM or within 15 minutes after its conclusion.
As on the record date of August 26, 2026, the company had 130,410 shareholders. A total of 92 shareholders attended the meeting through video conferencing, comprising five promoters and promoter group members and 87 public shareholders. No shareholders attended in person or through proxy.
Document Inspection
Statutory registers and relevant documents required for the AGM were made available for electronic inspection. Members interested in inspecting these documents were instructed to contact the company via email with their name, demat account details, email ID, and mobile number.
Historical Stock Returns for IOL Chemicals & Pharmaceuticals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.10% | +9.29% | +28.74% | +157.88% | +102.25% | +69.35% |
How might the clean audit reports from M/s. Ashwani & Associates influence institutional investor confidence in IOL Chemicals' financial transparency for FY27?
What strategic initiatives is the board likely to prioritize following the re-appointment of Mr. Kushal Kumar Rana to ensure continuity in governance?
Could the low physical attendance (zero in-person) and reliance on video conferencing signal a long-term shift in shareholder engagement strategies for the company?
20
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
